These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 18625752)

  • 21. Endpoints in PAH clinical trials in the era of combination therapy: how do we decide whether something is working without going bankrupt?
    McGlinchey N; Peacock AJ
    Drug Discov Today; 2014 Aug; 19(8):1236-40. PubMed ID: 24814434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyzing the short-term effect of placebo therapy in pulmonary arterial hypertension: potential implications for the design of future clinical trials.
    Helman DL; Brown AW; Jackson JL; Shorr AF
    Chest; 2007 Sep; 132(3):764-72. PubMed ID: 17505027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surrogate and combined end points in pulmonary arterial hypertension.
    Ventetuolo CE; Benza RL; Peacock AJ; Zamanian RT; Badesch DB; Kawut SM
    Proc Am Thorac Soc; 2008 Jul; 5(5):617-22. PubMed ID: 18625754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upfront combination therapy: does the AMBITION study herald a new era in the treatment of pulmonary arterial hypertension?
    Nathan SD; Corris PA
    Thorax; 2016 Feb; 71(2):107-9. PubMed ID: 26598387
    [No Abstract]   [Full Text] [Related]  

  • 25. Pulmonary hypertension trials: how can we do better?
    Hill NS; Roberts K; Preston I
    Expert Rev Respir Med; 2015 Oct; 9(5):551-8. PubMed ID: 26290120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Strategies for the Conduct of Clinical Trials in Pediatric Pulmonary Arterial Hypertension: Outcome of a Multistakeholder Meeting With Patients, Academia, Industry, and Regulators, Held at the European Medicines Agency on Monday, June 12, 2017.
    Ollivier C; Sun H; Amchin W; Beghetti M; Berger RMF; Breitenstein S; Garnett C; Gullberg N; Hassel P; Ivy D; Kawut SM; Klein A; Lesage C; Migdal M; Nije B; Odermarsky M; Strait J; de Graeff PA; Stockbridge N
    J Am Heart Assoc; 2019 May; 8(10):e011306. PubMed ID: 31088189
    [No Abstract]   [Full Text] [Related]  

  • 27. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review.
    Fogel DB
    Contemp Clin Trials Commun; 2018 Sep; 11():156-164. PubMed ID: 30112460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of severe pulmonary arterial hypertension.
    Vachiéry JL; Simonneau G
    Eur Respir Rev; 2010 Dec; 19(118):279-87. PubMed ID: 21119186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension.
    Sweeney L; Voelkel NF
    Eur J Med Res; 2009 Sep; 14(10):433-42. PubMed ID: 19748850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Two years of multidisciplinary diagnostic and therapeutic experience in patients with pulmonary arterial hypertension].
    Tokgözoğlu L; Akdoğan A; Okutucu S; Kaya EB; Aytemir K; Ozkutlu H
    Turk Kardiyol Dern Ars; 2009 Sep; 37(6):378-83. PubMed ID: 20019450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.
    Benza RL; Gomberg-Maitland M; Naeije R; Arneson CP; Lang IM
    J Heart Lung Transplant; 2011 Sep; 30(9):982-9. PubMed ID: 21531577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
    Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
    Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension.
    Galiè N; Seeger W; Naeije R; Simonneau G; Rubin LJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):81S-88S. PubMed ID: 15194183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with pulmonary arterial hypertension in clinical trials: who are they?
    Hill NS; Preston IR; Roberts KE
    Proc Am Thorac Soc; 2008 Jul; 5(5):603-9. PubMed ID: 18625752
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.